PharmaTher Signs License Agreement for Patented Ketamine Treatment Jan 22 • 3 min read PharmaTher has entered an agreement with the National Health Research Institutes of Taiwan to develop and commercialize a patented formulation of FDA-approved ketamine and betaine combination called KETABET.
January, 2021 Update: Psychedelic Index Adds 7 New Companies Jan 22 • 1 min read Psychedelic Invest is excited to announce that we’ve added 7 new companies to the Psychedelic Invest Index.
Mydecine Innovations Group Included in First-Ever Psychedelics ETF Jan 22 • 3 min read Mydecine Innovations Group has been included in the first-ever Psychedelics Exchanged Traded Fund (ETF).
Revive Therapeutics Announces $10 Million Bought Deal Offering of Units Jan 21 • 5 min read Revive Therapeutics Ltd. announced that is has entered into an agreement with underwriters have agreed to purchase 20,000,000 units at a price of $0.50 per equity unit for gross proceeds to the company of $10,000,000.
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD Jan 20 • 4 min read MindMed announced today the start of the first ever clinical trial measuring and evaluating MDMA and LSD used in combination in the human body.